1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Coral Laboratories Limited

Coral Laboratories Limited

CORALAB.BO
Coral Laboratories LimitedIN flagBombay Stock Exchange
617.00
INR
+7.25
- -
2.20BMarket Cap

Total Valuation

Coral Laboratories Limited carries a market capitalization of 2.20B, placing it among publicly traded companies globally. Its enterprise value stands at 348.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.20B
Enterprise Value348.30M

Share Statistics

Coral Laboratories Limited currently has 3.57M shares outstanding.

Shares Outstanding3.57M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Coral Laboratories Limited trades at a trailing price-to-earnings ratio of 8.08. The price-to-sales ratio is 1.54, and the price-to-book ratio stands at 37.05.

PE Ratio8.08
PS Ratio1.54
PB Ratio37.05
P/TBV Ratio0.63
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Coral Laboratories Limited trades at an EV/EBITDA multiple of 2.66 and an EV/FCF ratio of 286.56. The EV/Sales ratio of 0.41 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 2.66 provides insight into valuation relative to core operating earnings.

EV / Sales0.41
EV / EBITDA2.66
EV / EBIT2.66
EV / FCF286.56

Financial Position

Coral Laboratories Limited maintains a current ratio of 6.48, meaning it holds 6.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.07, indicating elevated leverage, while an interest coverage ratio of 76.27 demonstrates strong ability to service its debt obligations.

Current Ratio6.48
Quick Ratio3.73
Debt / Equity2.07
Debt / EBITDA0.33
Interest Coverage76.27

Financial Efficiency

Coral Laboratories Limited posts a return on equity of 458.60 and a return on invested capital of 4.21.

Return on Equity (ROE)458.60
Return on Assets (ROA)6.97
Return on Invested Capital (ROIC)4.21
Return on Capital Employed (ROCE)219.62
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.34

Taxes

Over the trailing twelve months, Coral Laboratories Limited has paid 67.34M in income taxes, reflecting an effective tax rate of 29.13.

Income Tax67.34M
Effective Tax Rate29.13

Stock Price Statistics

Coral Laboratories Limited's stock has gained approximately 4.594% over the past 52 weeks. The 50-day moving average sits at 500.13, while the 200-day moving average is 469.91.

Beta (5Y)N/A
52-Week Price Change4.594%
50-Day Moving Average500.13
200-Day Moving Average469.91
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Coral Laboratories Limited generated 859.00M in revenue and converted that into 163.84M in net income, yielding earnings per share of 45.86. EBITDA reached 130.80M, while operating income came in at 130.80M.

Revenue859.00M
Gross Profit503.65M
Operating Income130.80M
Pretax Income231.18M
Net Income163.84M
EBITDA130.80M
EBIT130.80M
Earnings Per Share (EPS)45.86

Balance Sheet

Coral Laboratories Limited holds 1.02B in cash and equivalents against 43.27M in total debt, resulting in a net debt position of 29.56M. Total book value stands at 35.73M, with working capital of 1.50B providing operational flexibility.

Cash & Cash Equivalents1.02B
Total Debt43.27M
Net Debt29.56M
Equity (Book Value)35.73M
Book Value Per Share10.00
Working Capital1.50B

Margins

Coral Laboratories Limited operates with a gross margin of 58.63, reflecting its pricing power and cost economics. The operating margin of 15.23 and net profit margin of 19.07 provide insight into operational efficiency.

Gross Margin58.63
Operating Margin15.23
Pretax Margin26.91
Profit Margin19.07
EBITDA Margin15.23

Scores

Coral Laboratories Limited posts an Altman Z-Score of 3.80, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.80